Systematic intervention of transcription for identifying network response to disease and cellular phenotypes

MOTIVATION A major challenge in post-genomic research has been to understand how physiological and pathological phenotypes arise from the networks of expressed genes. Here, we addressed this issue by developing an algorithm to mimic the behavior of regulatory networks in silico and to identify the dynamic response to disease and changing cellular conditions. RESULTS With regulatory pathway and gene expression data as input, the algorithm provides quantitative assessments of a wide range of responses, including susceptibility to disease, potential usefulness of a given drug, or consequences to such external stimuli as pharmacological interventions or caloric restriction. The algorithm is particularly amenable to the analysis of systems that are difficult to recapitulate in vitro, yet they may have important clinical value. The hypotheses derived from the algorithm were biologically relevant and were successfully validated via independent experiments, as illustrated here in the analysis of the leukemia-associated BCR-ABL pathway and the insulin/IGF pathway related to longevity. The algorithm correctly identified the leukemia drug target and genes important for longevity, and also provided new insights into our understanding of these two processes. AVAILABILITY The software package is available upon request to the authors.

[1]  C. Kenyon,et al.  A C. elegans mutant that lives twice as long as wild type , 1993, Nature.

[2]  Hidde de Jong,et al.  Modeling and Simulation of Genetic Regulatory Systems: A Literature Review , 2002, J. Comput. Biol..

[3]  P. Bourgine,et al.  Topological and causal structure of the yeast transcriptional regulatory network , 2002, Nature Genetics.

[4]  Michael L. Bittner,et al.  Growing genetic regulatory networks from seed genes , 2004, Bioinform..

[5]  K. Calame,et al.  Signaling Pathways Activated by Oncogenic Forms of Abl Tyrosine Kinase* , 1999, The Journal of Biological Chemistry.

[6]  Edward R. Dougherty,et al.  Coefficient of determination in nonlinear signal processing , 2000, Signal Process..

[7]  Edward R. Dougherty,et al.  Probabilistic Boolean networks: a rule-based uncertainty model for gene regulatory networks , 2002, Bioinform..

[8]  David Gems,et al.  Shared Transcriptional Signature in Caenorhabditis elegans Dauer Larvae and Long-lived daf-2 Mutants Implicates Detoxification System in Longevity Assurance* , 2004, Journal of Biological Chemistry.

[9]  S. Huang,et al.  Genomics, complexity and drug discovery: insights from Boolean network models of cellular regulation. , 2001, Pharmacogenomics.

[10]  Yi-Ching Hsieh,et al.  In chronic myeloid leukemia white cells from cytogenetic responders and non-responders to imatinib have very similar gene expression signatures. , 2005, Haematologica.

[11]  L. Breuer.  Introduction to Stochastic Processes , 2022, Statistical Methods for Climate Scientists.

[12]  S. Muta,et al.  Use of gene networks from full genome microarray libraries to identify functionally relevant drug-affected genes and gene regulation cascades. , 2003, DNA research : an international journal for rapid publication of reports on genes and genomes.

[13]  E. Dougherty,et al.  Gene perturbation and intervention in probabilistic Boolean networks. , 2002, Bioinformatics.

[14]  T. Speed,et al.  Summaries of Affymetrix GeneChip probe level data. , 2003, Nucleic acids research.

[15]  Hongwei Yu,et al.  Late gestational lung hypoplasia in a mouse model of the Smith-Lemli-Opitz syndrome , 2004, BMC Developmental Biology.

[16]  R. W. Padgett,et al.  TGFβ-related pathways: roles in Caenorhabditis elegans development , 2000 .

[17]  Raymond H. Myers,et al.  Probability and Statistics for Engineers and Scientists. , 1973 .

[18]  S. Huang,et al.  Shape-dependent control of cell growth, differentiation, and apoptosis: switching between attractors in cell regulatory networks. , 2000, Experimental cell research.

[19]  C. Sawyers,et al.  Signal transduction by wild-type and leukemogenic Abl proteins. , 1997, Biochimica et biophysica acta.

[20]  C. Kenyon,et al.  Regulation of the Caenorhabditis elegans longevity protein DAF-16 by insulin/IGF-1 and germline signaling , 2001, Nature Genetics.

[21]  C. Sawyers,et al.  Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. , 2001, The New England journal of medicine.

[22]  O. Witte,et al.  Tyrosine kinase activity and transformation potency of bcr-abl oncogene products. , 1990, Science.

[23]  J. Liao,et al.  Non-nuclear actions of estrogen: new targets for prevention and treatment of cardiovascular disease. , 2002, Molecular interventions.

[24]  Todd R Golub,et al.  Gene expression–based high-throughput screening(GE-HTS) and application to leukemia differentiation , 2004, Nature Genetics.

[25]  G. Patterson,et al.  Regulation of signaling genes by TGFβ during entry into dauer diapause in C. elegans , 2004, BMC Developmental Biology.

[26]  K Sivakumar,et al.  General nonlinear framework for the analysis of gene interaction via multivariate expression arrays. , 2000, Journal of biomedical optics.

[27]  S. Teichmann,et al.  Gene regulatory network growth by duplication , 2004, Nature Genetics.

[28]  S Fuhrman,et al.  Reveal, a general reverse engineering algorithm for inference of genetic network architectures. , 1998, Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing.

[29]  Michal Linial,et al.  Using Bayesian Networks to Analyze Expression Data , 2000, J. Comput. Biol..

[30]  Edward R. Dougherty,et al.  CAN MARKOV CHAIN MODELS MIMIC BIOLOGICAL REGULATION , 2002 .

[31]  Cori Bargmann,et al.  Genes that act downstream of DAF-16 to influence the lifespan of Caenorhabditis elegans , 2003, Nature.

[32]  Satoru Miyano,et al.  Use of Gene Networks for Identifying and Validating Drug Targets , 2003, J. Bioinform. Comput. Biol..

[33]  D. A. Baxter,et al.  Modeling transcriptional control in gene networks—methods, recent results, and future directions , 2000, Bulletin of mathematical biology.

[34]  S. Shen-Orr,et al.  Network motifs in the transcriptional regulation network of Escherichia coli , 2002, Nature Genetics.

[35]  D. Pe’er,et al.  Module networks: identifying regulatory modules and their condition-specific regulators from gene expression data , 2003, Nature Genetics.

[36]  G. Ruvkun,et al.  daf-2, daf-16 and daf-23: genetically interacting genes controlling Dauer formation in Caenorhabditis elegans. , 1994, Genetics.